PHAXIAM Therapeutics S.A. (PHXM) — Financial Flexibility Index
PHAXIAM Therapeutics S.A. (PHXM) has a Financial Flexibility Index of -0.33x as of June 2024. Free cash flow of €-7.90 Million (operating CF €-8.34 Million minus capex €437.00K) represents 0% of total liabilities (€23.66 Million). Also explore PHAXIAM Therapeutics S.A. annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PHAXIAM Therapeutics S.A. Financial Flexibility Index (2012–2023)
Historical Financial Flexibility Index trend for PHAXIAM Therapeutics S.A. across 12 annual periods. Check strategic asset allocation of PHAXIAM Therapeutics S.A. to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for PHAXIAM Therapeutics S.A. (2012–2023)
Year-by-year free cash flow to debt coverage for PHAXIAM Therapeutics S.A.. For the full company profile including market capitalisation, see PHXM company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.94x | €-24.21 Million | €-24.43 Million | €25.70 Million | ▲ +34.1% |
| 2022 | -1.43x | €-31.90 Million | €-31.99 Million | €22.32 Million | ▼ -10.4% |
| 2021 | -1.29x | €-56.85 Million | €-57.14 Million | €43.92 Million | ▼ -36.9% |
| 2020 | -0.95x | €-50.91 Million | €-52.05 Million | €53.86 Million | ▼ -33.4% |
| 2019 | -0.71x | €-23.37 Million | €-43.51 Million | €32.99 Million | ▲ +37.1% |
| 2018 | -1.13x | €-25.05 Million | €-39.27 Million | €22.24 Million | ▲ +32.3% |
| 2017 | -1.66x | €-23.01 Million | €-24.70 Million | €13.84 Million | ▲ +2.4% |
| 2016 | -1.70x | €-15.89 Million | €-17.64 Million | €9.33 Million | ▲ +30.1% |
| 2015 | -2.44x | €-14.31 Million | €-14.58 Million | €5.87 Million | ▼ -70.9% |
| 2014 | -1.43x | €-6.82 Million | €-7.24 Million | €4.78 Million | ▼ -2.9% |
| 2013 | -1.39x | €-6.05 Million | €-6.47 Million | €4.36 Million | ▼ -3014.3% |
| 2012 | 0.05x | €673.90K | €621.40K | €14.17 Million | — |